H-D-Glu(Me)-OMe*HCl

H-D-Glu(Me)-OMe*HCl is a protected/derivatized amino acid derivative based on glutamic acid in which the side-chain carboxyl group is modified as a methyl ester and the amino acid is present as a methyl ester, with the alpha-amino group bearing an N-deuterium label (H-D) and the compound supplied as a hydrochloride salt. The molecule contains an esterified carboxyl functionality (-CO2Me) and a free carboxyl group is not present in the named form, while the side chain features a substituted glutamate backbone with a Me substituent on the side-chain carbon as indicated by "Glu(Me)," and the "*HCl" denotes protonation of the basic site for salt formation. This isotopically labeled, esterified glutamate analogue is used in peptide- and amino-acid-derivative synthesis and analytical studies where deuterium labeling and controlled ester functionality are relevant for tracking, method development, or preparing further glutamate-based building blocks.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25692

CAS No:27025-25-8

Synonyms/Alias:27025-25-8;DimethylD-GlutamateHydrochloride;(R)-Dimethyl2-aminopentanedioatehydrochloride;H-D-GLU(OME)-OMEHCL;H-D-Glu(OMe)-OMe.HCl;D-GlutamicAcidDimethylEsterHydrochloride;H-D-GLU-OMEHCL;SCHEMBL624146;CTK8B1351;MFUPLHQOVIUESQ-NUBCRITNSA-N;MolPort-003-983-029;ACT07728;dimethyl(R)-glutamatehydrochloride;ANW-26109;AKOS015849456;AKOS015900668;AM83094;RTR-012191;AK-49637;KB-50050;TR-012191;D3560;FT-0686507;ST24035538;D-Glutamicacid,dimethylester,hydrochloride

Chemical Name:D-Glutamic acid di-methyl ester hydrochloride

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C7H14ClNO4
M.W/Mr.
175,18*36,45 g/mole

H-D-Glu(Me)-OMe*HCl is a protected glutamic acid derivative presented as a hydrochloride salt, featuring a side-chain carboxyl functionality masked as a methyl ester while the α-carboxyl is present as a methyl ester (OMe) and the α-amino group is acetylated (H-D- prefix indicating deuterated stereochemical labeling at the amino-bearing center). The structure therefore combines an esterified α-carboxyl, an esterified side-chain carboxyl, and an N-acetylated amino group, which together modulate polarity and suppress undesired amide formation during peptide coupling. The D configuration at the chiral center provides stereochemical control for incorporation into peptides and peptide-like scaffolds where enantiomeric identity influences conformational preferences and recognition. Salt formation improves handling of the amino acid ester hydrochloride while retaining compatibility with standard amino acid derivatization and downstream deprotection strategies that regenerate carboxylic acid functionality for coupling or further functional transformation.

1. Protected Amino Acid Synthesis

H-D-Glu(Me)-OMe*HCl supports protected amino acid chemistry as an amino acid ester hydrochloride in which both carboxyl groups are esterified, limiting side reactions such as premature salt formation or uncontrolled acyl transfer during coupling steps. The N-acetylated amine and methyl ester groups enable sequential protection/deprotection logic, allowing conversion to free carboxylic acids when carboxyl activation is required for peptide bond formation or for preparing additional derivatives. Deuterium labeling at the α-stereocenter can be retained through early synthetic operations, making the compound suitable for building chiral amino acid intermediates that require traceable stereochemical identity. Downstream, the ester-to-acid transition and amine deprotection can be used to generate peptide-ready glutamate building blocks for synthetic organic chemistry and industrial intermediate preparation.

2. Peptide Synthesis

H-D-Glu(Me)-OMe*HCl is applicable to peptide synthesis workflows requiring a glutamate-derived chiral building block with controlled stereochemistry and protected functional groups. The esterified side-chain carboxyl (Me) and esterified α-carboxyl (OMe) reduce competing nucleophilicity, while the N-acetylated amino group can be handled under conditions compatible with peptide coupling after appropriate conversion to the coupling-ready form. The D stereochemistry can be leveraged to construct D-glutamate-containing peptides or peptidomimetic fragments where configurational inversion relative to L-glutamate changes backbone geometry and side-chain orientation. Resulting peptide analogs can serve as substrates for biochemical assays, as standards for analytical method development, or as intermediates in the synthesis of longer peptide sequences.

3. Side-Chain Functionalization

H-D-Glu(Me)-OMe*HCl is suitable for side-chain functionalization strategies that begin from a glutamate scaffold bearing an ester-protected side-chain carboxyl. The methyl ester can be transformed into activated carboxylic acid derivatives for subsequent derivatization, enabling formation of amide, ester, or other acyl-linked motifs while maintaining the D stereocenter. The N-acetyl protection pattern helps preserve the amino functionality during manipulations focused on carboxyl chemistry, supporting targeted modification of the glutamate side chain for structure-activity relationship studies. Downstream products can include functionalized glutamate residues used in peptidomimetic construction, chemical biology probes, or polymer-reactive intermediates derived from amino acid chemistry.

4. Isotope-Labeled Standards

H-D-Glu(Me)-OMe*HCl can be employed for isotope-labeling applications in analytical research and biochemical method development where deuterium at the stereogenic center provides mass-shifted detection. The hydrochloride salt form improves reproducibility in handling of the amino acid ester, while the protected ester and N-acetyl features help stabilize the molecule during sample preparation and derivatization steps. The defined D configuration supports use as a stereochemically specific internal standard for monitoring amino acid ester hydrolysis, peptide coupling, or carboxyl activation reactions in synthetic and analytical workflows. Incorporation of this labeled glutamate derivative into peptide fragments can also support LC-MS/MS quantification of labeled species and tracking of stereochemical integrity through downstream transformations.

5. Pharmaceutical Intermediate Preparation

H-D-Glu(Me)-OMe*HCl is relevant to pharmaceutical intermediate preparation and fine chemical synthesis where glutamate-derived chiral fragments are required for building peptidomimetic or amino acid-based structures. The dual ester protection pattern supports controlled reactivity, allowing selective conversion of carboxyl functionality into activated intermediates under process-compatible conditions while limiting undesired cross-reactivity from free acids. The D stereocenter provides configurational control for synthesizing enantiomerically defined intermediates used in medicinal chemistry libraries and process development. Salt formation and protected-group architecture also align with manufacturing-oriented handling of amino acid ester intermediates that must be carried through multi-step sequences before final deprotection and coupling.

Size
5 g;25 g;
InChI
1S/C7H13NO4.ClH/c1-11-6(9)4-3-5(8)7(10)12-2;/h5H,3-4,8H2,1-2H3;1H/t5-;/m1./s1
InChI Key
MFUPLHQOVIUESQ-NUBCRITNSA-N
Canonical SMILES
COC(=O)CCC(C(=O)OC)N.Cl

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesPeptide Modification ServicesCustom Conjugation ServicePeptide CDMOPeptide Synthesis ServicesPeptide Nucleic Acids SynthesisEpitope Mapping ServicescGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers